

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.11920364 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.11920364 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.01812079 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.01812079 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 4.37210465 |
| 6 | cellular ketone body metabolic process (GO:0046950) | 4.32057889 |
| 7 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.22445362 |
| 8 | piRNA metabolic process (GO:0034587) | 4.11313029 |
| 9 | kynurenine metabolic process (GO:0070189) | 4.06067741 |
| 10 | nucleobase catabolic process (GO:0046113) | 4.03854950 |
| 11 | lysine catabolic process (GO:0006554) | 3.96712943 |
| 12 | lysine metabolic process (GO:0006553) | 3.96712943 |
| 13 | establishment of protein localization to Golgi (GO:0072600) | 3.96458987 |
| 14 | regulation of cilium movement (GO:0003352) | 3.95071562 |
| 15 | * short-chain fatty acid metabolic process (GO:0046459) | 3.93099933 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.79703870 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.78249855 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.78249855 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.78249855 |
| 20 | aspartate family amino acid catabolic process (GO:0009068) | 3.74910007 |
| 21 | exogenous drug catabolic process (GO:0042738) | 3.73832025 |
| 22 | glyoxylate metabolic process (GO:0046487) | 3.73562345 |
| 23 | protein targeting to Golgi (GO:0000042) | 3.72331916 |
| 24 | ketone body metabolic process (GO:1902224) | 3.69406759 |
| 25 | * fatty acid beta-oxidation (GO:0006635) | 3.68875440 |
| 26 | bile acid biosynthetic process (GO:0006699) | 3.65589670 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 3.63242605 |
| 28 | branched-chain amino acid catabolic process (GO:0009083) | 3.63127698 |
| 29 | sulfur amino acid catabolic process (GO:0000098) | 3.61982581 |
| 30 | acetyl-CoA metabolic process (GO:0006084) | 3.60846652 |
| 31 | coenzyme catabolic process (GO:0009109) | 3.60077815 |
| 32 | amine catabolic process (GO:0009310) | 3.59178847 |
| 33 | cellular biogenic amine catabolic process (GO:0042402) | 3.59178847 |
| 34 | NADH metabolic process (GO:0006734) | 3.58349059 |
| 35 | amino-acid betaine metabolic process (GO:0006577) | 3.57994426 |
| 36 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.56164952 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.54483410 |
| 38 | 2-oxoglutarate metabolic process (GO:0006103) | 3.51863408 |
| 39 | S-adenosylmethionine metabolic process (GO:0046500) | 3.50947022 |
| 40 | * fatty acid catabolic process (GO:0009062) | 3.50862593 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.48864951 |
| 42 | alpha-linolenic acid metabolic process (GO:0036109) | 3.46951809 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46236313 |
| 44 | protein polyglutamylation (GO:0018095) | 3.46118180 |
| 45 | * fatty acid oxidation (GO:0019395) | 3.44002464 |
| 46 | biotin metabolic process (GO:0006768) | 3.43808439 |
| 47 | sulfation (GO:0051923) | 3.42372992 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 3.41473182 |
| 49 | carnitine shuttle (GO:0006853) | 3.41196503 |
| 50 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.40080298 |
| 51 | succinate metabolic process (GO:0006105) | 3.39263993 |
| 52 | * lipid oxidation (GO:0034440) | 3.36863643 |
| 53 | fatty acid transmembrane transport (GO:1902001) | 3.36368080 |
| 54 | cysteine metabolic process (GO:0006534) | 3.34127826 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 3.33685981 |
| 56 | * monocarboxylic acid catabolic process (GO:0072329) | 3.32905981 |
| 57 | tricarboxylic acid cycle (GO:0006099) | 3.31951268 |
| 58 | glutamate metabolic process (GO:0006536) | 3.27337146 |
| 59 | urea cycle (GO:0000050) | 3.26488821 |
| 60 | urea metabolic process (GO:0019627) | 3.26488821 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.26426015 |
| 62 | retinal cone cell development (GO:0046549) | 3.22329230 |
| 63 | * carboxylic acid catabolic process (GO:0046395) | 3.16500814 |
| 64 | * organic acid catabolic process (GO:0016054) | 3.16500814 |
| 65 | branched-chain amino acid metabolic process (GO:0009081) | 3.16401048 |
| 66 | auditory receptor cell differentiation (GO:0042491) | 3.14644299 |
| 67 | negative regulation of mast cell activation (GO:0033004) | 3.12315843 |
| 68 | dicarboxylic acid catabolic process (GO:0043649) | 3.12157195 |
| 69 | bile acid metabolic process (GO:0008206) | 3.10510217 |
| 70 | amino acid salvage (GO:0043102) | 3.08848655 |
| 71 | L-methionine salvage (GO:0071267) | 3.08848655 |
| 72 | L-methionine biosynthetic process (GO:0071265) | 3.08848655 |
| 73 | triglyceride homeostasis (GO:0070328) | 3.08507036 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.08507036 |
| 75 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.07532395 |
| 76 | benzene-containing compound metabolic process (GO:0042537) | 3.07108688 |
| 77 | carnitine metabolic process (GO:0009437) | 3.05726888 |
| 78 | oxidative demethylation (GO:0070989) | 3.05664475 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.05663859 |
| 80 | nonmotile primary cilium assembly (GO:0035058) | 3.04994047 |
| 81 | ethanol oxidation (GO:0006069) | 3.04879964 |
| 82 | high-density lipoprotein particle remodeling (GO:0034375) | 3.04835212 |
| 83 | regulation of sequestering of triglyceride (GO:0010889) | 3.04427634 |
| 84 | righting reflex (GO:0060013) | 3.03076090 |
| 85 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.01469226 |
| 86 | regulation of meiosis I (GO:0060631) | 3.00131339 |
| 87 | multicellular organism reproduction (GO:0032504) | 2.98147359 |
| 88 | negative regulation of lipase activity (GO:0060192) | 2.96480256 |
| 89 | DNA methylation involved in gamete generation (GO:0043046) | 2.95370619 |
| 90 | homocysteine metabolic process (GO:0050667) | 2.94922256 |
| 91 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.94602282 |
| 92 | regulation of acrosome reaction (GO:0060046) | 2.92730890 |
| 93 | xenobiotic catabolic process (GO:0042178) | 2.92555336 |
| 94 | signal peptide processing (GO:0006465) | 2.92551906 |
| 95 | tyrosine metabolic process (GO:0006570) | 2.91457326 |
| 96 | methionine biosynthetic process (GO:0009086) | 2.90005366 |
| 97 | methionine metabolic process (GO:0006555) | 2.89663369 |
| 98 | thioester metabolic process (GO:0035383) | 2.87571097 |
| 99 | acyl-CoA metabolic process (GO:0006637) | 2.87571097 |
| 100 | gamma-aminobutyric acid transport (GO:0015812) | 2.87169033 |
| 101 | respiratory electron transport chain (GO:0022904) | 2.85659119 |
| 102 | regulation of fibrinolysis (GO:0051917) | 2.85556537 |
| 103 | NAD metabolic process (GO:0019674) | 2.85247032 |
| 104 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.83858292 |
| 105 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.81216827 |
| 106 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.81202008 |
| 107 | photoreceptor cell maintenance (GO:0045494) | 2.80503308 |
| 108 | regulation of fatty acid oxidation (GO:0046320) | 2.80216367 |
| 109 | indolalkylamine metabolic process (GO:0006586) | 2.79207636 |
| 110 | negative regulation of fibrinolysis (GO:0051918) | 2.79184295 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79129724 |
| 112 | acyl-CoA biosynthetic process (GO:0071616) | 2.78603050 |
| 113 | thioester biosynthetic process (GO:0035384) | 2.78603050 |
| 114 | electron transport chain (GO:0022900) | 2.78286558 |
| 115 | omega-hydroxylase P450 pathway (GO:0097267) | 2.77950561 |
| 116 | positive regulation of fatty acid oxidation (GO:0046321) | 2.77769471 |
| 117 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.77297771 |
| 118 | ATP synthesis coupled proton transport (GO:0015986) | 2.77297771 |
| 119 | epoxygenase P450 pathway (GO:0019373) | 2.76891394 |
| 120 | carnitine transmembrane transport (GO:1902603) | 2.75995220 |
| 121 | regulation of protein activation cascade (GO:2000257) | 2.74875147 |
| 122 | cellular modified amino acid catabolic process (GO:0042219) | 2.74736327 |
| 123 | protein targeting to vacuole (GO:0006623) | 2.74551264 |
| 124 | protein targeting to lysosome (GO:0006622) | 2.74551264 |
| 125 | establishment of protein localization to vacuole (GO:0072666) | 2.74551264 |
| 126 | oxaloacetate metabolic process (GO:0006107) | 2.72893789 |
| 127 | cellular glucuronidation (GO:0052695) | 2.72107529 |
| 128 | regulation of mitochondrial fission (GO:0090140) | 2.71530372 |
| 129 | carnitine transport (GO:0015879) | 2.71222994 |
| 130 | amino-acid betaine transport (GO:0015838) | 2.71222994 |
| 131 | * small molecule catabolic process (GO:0044282) | 2.70693251 |
| 132 | complement activation, alternative pathway (GO:0006957) | 2.69069032 |
| 133 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.68497336 |
| 134 | protein carboxylation (GO:0018214) | 2.68497336 |
| 135 | detection of light stimulus involved in visual perception (GO:0050908) | 2.68267626 |
| 136 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.68267626 |
| 137 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.67713752 |
| 138 | reflex (GO:0060004) | 2.67118343 |
| 139 | regulation of microtubule-based movement (GO:0060632) | 2.65869333 |
| 140 | positive regulation of lipid catabolic process (GO:0050996) | 2.63520731 |
| 141 | drug catabolic process (GO:0042737) | 2.62205312 |
| 142 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.61998058 |
| 143 | regulation of bile acid biosynthetic process (GO:0070857) | 2.61375709 |
| 144 | indole-containing compound metabolic process (GO:0042430) | 2.60761536 |
| 145 | cofactor catabolic process (GO:0051187) | 2.60568827 |
| 146 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.60039486 |
| 147 | phospholipid homeostasis (GO:0055091) | 2.60035530 |
| 148 | NAD biosynthetic process (GO:0009435) | 2.58062573 |
| 149 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.57595071 |
| 150 | fucose catabolic process (GO:0019317) | 2.57542695 |
| 151 | L-fucose metabolic process (GO:0042354) | 2.57542695 |
| 152 | L-fucose catabolic process (GO:0042355) | 2.57542695 |
| 153 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.56521009 |
| 154 | brain morphogenesis (GO:0048854) | 2.56341141 |
| 155 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.55843185 |
| 156 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.55165324 |
| 157 | protein localization to Golgi apparatus (GO:0034067) | 2.54637790 |
| 158 | response to nitrosative stress (GO:0051409) | 2.54306957 |
| 159 | anterograde synaptic vesicle transport (GO:0048490) | 2.50917489 |
| 160 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.50897310 |
| 161 | alkaloid metabolic process (GO:0009820) | 2.50741448 |
| 162 | positive regulation of mitochondrial fission (GO:0090141) | 2.50179217 |
| 163 | glucuronate metabolic process (GO:0019585) | 2.47294316 |
| 164 | uronic acid metabolic process (GO:0006063) | 2.47294316 |
| 165 | neural tube formation (GO:0001841) | 2.46577718 |
| 166 | nitric oxide biosynthetic process (GO:0006809) | 2.44536311 |
| 167 | positive regulation of amino acid transport (GO:0051957) | 2.43486052 |
| 168 | mRNA modification (GO:0016556) | 2.43329749 |
| 169 | cilium morphogenesis (GO:0060271) | 2.40936184 |
| 170 | retinal rod cell development (GO:0046548) | 2.40555791 |
| 171 | startle response (GO:0001964) | 2.38919692 |
| 172 | N-acetylglucosamine metabolic process (GO:0006044) | 2.38358320 |
| 173 | photoreceptor cell development (GO:0042461) | 2.37931180 |
| 174 | presynaptic membrane assembly (GO:0097105) | 2.37471282 |
| 175 | adaptation of signaling pathway (GO:0023058) | 2.35911900 |
| 176 | protein K11-linked deubiquitination (GO:0035871) | 2.33937584 |
| 177 | meiotic cell cycle (GO:0051321) | 2.33446497 |
| 178 | mechanosensory behavior (GO:0007638) | 2.31564578 |
| 179 | dopamine transport (GO:0015872) | 2.30138000 |
| 180 | gene silencing by RNA (GO:0031047) | 2.28826679 |
| 181 | phenylpropanoid metabolic process (GO:0009698) | 2.27898045 |
| 182 | serotonin metabolic process (GO:0042428) | 2.26623431 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.47189730 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.92744766 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.78552638 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.56039148 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.49076807 |
| 6 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.47650067 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.22113164 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09875512 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.03917211 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.81704648 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.72123441 |
| 12 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.46119677 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.38555192 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23807774 |
| 15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.10194747 |
| 16 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07844764 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05963633 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05368460 |
| 19 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.04243348 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02571270 |
| 21 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.01281785 |
| 22 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92159435 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.85829409 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80005251 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.77187882 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76770147 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.70435248 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70339893 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.68110794 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.67596239 |
| 31 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.65658603 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.64644807 |
| 33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.58756869 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.58146681 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.58146681 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.56106991 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55499788 |
| 38 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55118120 |
| 39 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51053033 |
| 40 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50931030 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49390886 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48951144 |
| 43 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48643132 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.48150711 |
| 45 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.46505815 |
| 46 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.46321079 |
| 47 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.45871221 |
| 48 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.44677445 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44373344 |
| 50 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42645918 |
| 51 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.41289871 |
| 52 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37381694 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.36850281 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.36536398 |
| 55 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.36198273 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.36172275 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35464842 |
| 58 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.34994923 |
| 59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34406740 |
| 60 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.33813939 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.33802471 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32147694 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.30623256 |
| 64 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.30623256 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.29523569 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.29285216 |
| 67 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.28670711 |
| 68 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.27004367 |
| 69 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.26026876 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.25839286 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25749247 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25161737 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23858337 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.22240878 |
| 75 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21055459 |
| 76 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.20895962 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19867525 |
| 78 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19069963 |
| 79 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.17942227 |
| 80 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17489747 |
| 81 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.16876886 |
| 82 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16742275 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15415855 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.14902257 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13916629 |
| 86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.13537807 |
| 87 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13434944 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13220827 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11380997 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11235394 |
| 91 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10049159 |
| 92 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10037250 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.09876255 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09430370 |
| 95 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08305085 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08195972 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07262912 |
| 98 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07172475 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.07172475 |
| 100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06851401 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.06002068 |
| 102 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05210842 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05105613 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04358079 |
| 105 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04101091 |
| 106 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03805324 |
| 107 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03536484 |
| 108 | P300_19829295_ChIP-Seq_ESCs_Human | 1.02733226 |
| 109 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00915829 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00874413 |
| 111 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00770873 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.00744958 |
| 113 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99029556 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98910039 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98567285 |
| 116 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.97545205 |
| 117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97287630 |
| 118 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96178390 |
| 119 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95427629 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.95271696 |
| 121 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94548330 |
| 122 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94056730 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93900547 |
| 124 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.93237909 |
| 125 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.93237909 |
| 126 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.92402558 |
| 127 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.92249251 |
| 128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90295542 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89027550 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87449346 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86869064 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86869064 |
| 133 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84698366 |
| 134 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82897906 |
| 135 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81599820 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.80391849 |
| 137 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80246380 |
| 138 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.80076534 |
| 139 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79865144 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.79323737 |
| 141 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79190721 |
| 142 | STAT3_23295773_ChIP-Seq_U87_Human | 0.79001439 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78167790 |
| 144 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77044438 |
| 145 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.75963184 |
| 146 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75214123 |
| 147 | TCF4_23295773_ChIP-Seq_U87_Human | 0.74519680 |
| 148 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.73291611 |
| 149 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72134376 |
| 150 | CBP_21632823_ChIP-Seq_H3396_Human | 0.71904747 |
| 151 | * AR_19668381_ChIP-Seq_PC3_Human | 0.71305326 |
| 152 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.71056069 |
| 153 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.71056069 |
| 154 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.70660917 |
| 155 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.70257523 |
| 156 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.69838001 |
| 157 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.69811210 |
| 158 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.69621569 |
| 159 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.69421195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.79304949 |
| 2 | MP0005360_urolithiasis | 4.41367642 |
| 3 | MP0005365_abnormal_bile_salt | 4.03466094 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.98142553 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.92015763 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.88719066 |
| 7 | MP0003183_abnormal_peptide_metabolism | 3.20695321 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.18555964 |
| 9 | MP0000569_abnormal_digit_pigmentation | 2.97297448 |
| 10 | MP0008877_abnormal_DNA_methylation | 2.58547008 |
| 11 | MP0003646_muscle_fatigue | 2.58470745 |
| 12 | MP0000751_myopathy | 2.42683557 |
| 13 | MP0004215_abnormal_myocardial_fiber | 2.37910012 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.23810830 |
| 15 | MP0005332_abnormal_amino_acid | 2.17337906 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 2.13675097 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.11696664 |
| 18 | MP0003718_maternal_effect | 2.08461117 |
| 19 | MP0004130_abnormal_muscle_cell | 2.00493954 |
| 20 | MP0003252_abnormal_bile_duct | 1.99475650 |
| 21 | MP0003195_calcinosis | 1.97071305 |
| 22 | MP0005083_abnormal_biliary_tract | 1.94385323 |
| 23 | MP0003880_abnormal_central_pattern | 1.87160263 |
| 24 | MP0001666_abnormal_nutrient_absorption | 1.82786535 |
| 25 | MP0006036_abnormal_mitochondrial_physio | 1.77344426 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 1.73038624 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.70848009 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 1.64740193 |
| 29 | MP0002822_catalepsy | 1.63955061 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.61068079 |
| 31 | MP0009840_abnormal_foam_cell | 1.60073022 |
| 32 | MP0003137_abnormal_impulse_conducting | 1.56641350 |
| 33 | MP0005330_cardiomyopathy | 1.56535153 |
| 34 | MP0004084_abnormal_cardiac_muscle | 1.52650749 |
| 35 | MP0004043_abnormal_pH_regulation | 1.50212677 |
| 36 | MP0004270_analgesia | 1.48386451 |
| 37 | MP0009745_abnormal_behavioral_response | 1.45070023 |
| 38 | MP0000749_muscle_degeneration | 1.44273213 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.43138912 |
| 40 | MP0005423_abnormal_somatic_nervous | 1.42771759 |
| 41 | MP0000427_abnormal_hair_cycle | 1.42130577 |
| 42 | MP0006054_spinal_hemorrhage | 1.41300979 |
| 43 | MP0004019_abnormal_vitamin_homeostasis | 1.40954199 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.40620219 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39961226 |
| 46 | MP0005670_abnormal_white_adipose | 1.38447557 |
| 47 | MP0004145_abnormal_muscle_electrophysio | 1.38299025 |
| 48 | MP0005535_abnormal_body_temperature | 1.37035450 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.35052799 |
| 50 | MP0002102_abnormal_ear_morphology | 1.34273496 |
| 51 | MP0002064_seizures | 1.33714173 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.30124596 |
| 53 | MP0003868_abnormal_feces_composition | 1.29540916 |
| 54 | MP0004085_abnormal_heartbeat | 1.28902728 |
| 55 | MP0003329_amyloid_beta_deposits | 1.27202725 |
| 56 | MP0001764_abnormal_homeostasis | 1.25438931 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.23320100 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.23230501 |
| 59 | MP0006035_abnormal_mitochondrial_morpho | 1.22925878 |
| 60 | MP0006276_abnormal_autonomic_nervous | 1.22922243 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.22725243 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.22534501 |
| 63 | MP0002272_abnormal_nervous_system | 1.21938889 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.21379690 |
| 65 | MP0002572_abnormal_emotion/affect_behav | 1.20546895 |
| 66 | MP0001529_abnormal_vocalization | 1.20186317 |
| 67 | MP0003633_abnormal_nervous_system | 1.19481304 |
| 68 | MP0005266_abnormal_metabolism | 1.19008634 |
| 69 | MP0005499_abnormal_olfactory_system | 1.18644524 |
| 70 | MP0005394_taste/olfaction_phenotype | 1.18644524 |
| 71 | MP0001486_abnormal_startle_reflex | 1.18206389 |
| 72 | MP0001485_abnormal_pinna_reflex | 1.17576328 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.17250723 |
| 74 | MP0005187_abnormal_penis_morphology | 1.16465980 |
| 75 | MP0000013_abnormal_adipose_tissue | 1.15651340 |
| 76 | MP0005620_abnormal_muscle_contractility | 1.15322241 |
| 77 | MP0009764_decreased_sensitivity_to | 1.14901063 |
| 78 | MP0009046_muscle_twitch | 1.12891355 |
| 79 | MP0003011_delayed_dark_adaptation | 1.12243284 |
| 80 | MP0001968_abnormal_touch/_nociception | 1.11935393 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.10623230 |
| 82 | MP0004147_increased_porphyrin_level | 1.10203265 |
| 83 | MP0002972_abnormal_cardiac_muscle | 1.08502087 |
| 84 | MP0006082_CNS_inflammation | 1.08244017 |
| 85 | MP0000747_muscle_weakness | 1.07611113 |
| 86 | MP0005666_abnormal_adipose_tissue | 1.06781311 |
| 87 | MP0004742_abnormal_vestibular_system | 1.06315280 |
| 88 | MP0005395_other_phenotype | 1.02768256 |
| 89 | MP0005647_abnormal_sex_gland | 1.01934775 |
| 90 | MP0004484_altered_response_of | 1.01848685 |
| 91 | MP0002928_abnormal_bile_duct | 1.01666328 |
| 92 | MP0008775_abnormal_heart_ventricle | 1.00737419 |
| 93 | MP0000609_abnormal_liver_physiology | 1.00716367 |
| 94 | MP0005410_abnormal_fertilization | 1.00289232 |
| 95 | MP0004087_abnormal_muscle_fiber | 0.99538720 |
| 96 | MP0004924_abnormal_behavior | 0.98112626 |
| 97 | MP0005386_behavior/neurological_phenoty | 0.98112626 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.98082922 |
| 99 | MP0008057_abnormal_DNA_replication | 0.97747468 |
| 100 | MP0001984_abnormal_olfaction | 0.97507031 |
| 101 | MP0006072_abnormal_retinal_apoptosis | 0.96268181 |
| 102 | MP0000230_abnormal_systemic_arterial | 0.95746948 |
| 103 | MP0005253_abnormal_eye_physiology | 0.95436110 |
| 104 | MP0003879_abnormal_hair_cell | 0.93993394 |
| 105 | MP0002735_abnormal_chemical_nociception | 0.92935903 |
| 106 | MP0002736_abnormal_nociception_after | 0.92512495 |
| 107 | MP0002971_abnormal_brown_adipose | 0.92022942 |
| 108 | MP0003656_abnormal_erythrocyte_physiolo | 0.91362467 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.90531683 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.90487325 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.90487325 |
| 112 | MP0000015_abnormal_ear_pigmentation | 0.90400363 |
| 113 | MP0002909_abnormal_adrenal_gland | 0.90348973 |
| 114 | MP0005451_abnormal_body_composition | 0.90032658 |
| 115 | MP0000516_abnormal_urinary_system | 0.89812370 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.89812370 |
| 117 | MP0002269_muscular_atrophy | 0.89480691 |
| 118 | MP0003724_increased_susceptibility_to | 0.89418714 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.89328310 |
| 120 | MP0002734_abnormal_mechanical_nocicepti | 0.88969510 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.86634876 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.86306947 |
| 123 | MP0006138_congestive_heart_failure | 0.85887929 |
| 124 | MP0010678_abnormal_skin_adnexa | 0.85735827 |
| 125 | MP0005310_abnormal_salivary_gland | 0.85590856 |
| 126 | MP0002106_abnormal_muscle_physiology | 0.82674778 |
| 127 | MP0005636_abnormal_mineral_homeostasis | 0.81165378 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.80471637 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.80453643 |
| 130 | MP0001905_abnormal_dopamine_level | 0.79825814 |
| 131 | MP0001944_abnormal_pancreas_morphology | 0.79038986 |
| 132 | MP0002229_neurodegeneration | 0.78468348 |
| 133 | MP0005448_abnormal_energy_balance | 0.78315744 |
| 134 | MP0000685_abnormal_immune_system | 0.78054950 |
| 135 | MP0009697_abnormal_copulation | 0.77830590 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.77489745 |
| 137 | MP0010234_abnormal_vibrissa_follicle | 0.77209804 |
| 138 | MP0005389_reproductive_system_phenotype | 0.76372977 |
| 139 | MP0003631_nervous_system_phenotype | 0.75853347 |
| 140 | MP0005334_abnormal_fat_pad | 0.75761973 |
| 141 | MP0008874_decreased_physiological_sensi | 0.75459678 |
| 142 | MP0005646_abnormal_pituitary_gland | 0.75382901 |
| 143 | MP0001919_abnormal_reproductive_system | 0.75108900 |
| 144 | MP0004142_abnormal_muscle_tone | 0.75048307 |
| 145 | MP0008872_abnormal_physiological_respon | 0.74734345 |
| 146 | MP0009785_altered_susceptibility_to | 0.72493721 |
| 147 | MP0003045_fibrosis | 0.69554090 |
| 148 | MP0004885_abnormal_endolymph | 0.68951354 |
| 149 | MP0000383_abnormal_hair_follicle | 0.66903986 |
| 150 | MP0003959_abnormal_lean_body | 0.65930054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Renal cortical cysts (HP:0000803) | 4.80134528 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.42266769 |
| 3 | * Ketosis (HP:0001946) | 4.33634208 |
| 4 | Ketoacidosis (HP:0001993) | 4.20679463 |
| 5 | * Hyperglycinemia (HP:0002154) | 3.94922038 |
| 6 | Hyperglycinuria (HP:0003108) | 3.90554017 |
| 7 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84393853 |
| 8 | * Abnormality of glycine metabolism (HP:0010895) | 3.84393853 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 3.83946378 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.79800733 |
| 11 | Abnormality of the renal cortex (HP:0011035) | 3.79448034 |
| 12 | * Hyperammonemia (HP:0001987) | 3.75308185 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 3.69139966 |
| 14 | Xanthomatosis (HP:0000991) | 3.60774363 |
| 15 | Hepatic necrosis (HP:0002605) | 3.48022507 |
| 16 | Intestinal atresia (HP:0011100) | 3.45842126 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.43992785 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.36459975 |
| 19 | Prolonged partial thromboplastin time (HP:0003645) | 3.36449599 |
| 20 | Medial flaring of the eyebrow (HP:0010747) | 3.34098417 |
| 21 | Sudden death (HP:0001699) | 3.33321673 |
| 22 | Cerebral edema (HP:0002181) | 3.29226472 |
| 23 | * Dicarboxylic aciduria (HP:0003215) | 3.21636212 |
| 24 | * Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.21636212 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 3.17081999 |
| 26 | Gaze-evoked nystagmus (HP:0000640) | 3.16769960 |
| 27 | Acute encephalopathy (HP:0006846) | 3.08151711 |
| 28 | Exercise-induced myalgia (HP:0003738) | 3.06460006 |
| 29 | Hypobetalipoproteinemia (HP:0003563) | 3.06193141 |
| 30 | Hepatocellular necrosis (HP:0001404) | 3.04441361 |
| 31 | Proximal tubulopathy (HP:0000114) | 3.01127531 |
| 32 | * Metabolic acidosis (HP:0001942) | 2.94385330 |
| 33 | Fair hair (HP:0002286) | 2.91439935 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.91175429 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.86642160 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.86084557 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.85089113 |
| 38 | * Abnormality of serum amino acid levels (HP:0003112) | 2.83912417 |
| 39 | Myoglobinuria (HP:0002913) | 2.82705982 |
| 40 | * Lethargy (HP:0001254) | 2.82362991 |
| 41 | Acute necrotizing encephalopathy (HP:0006965) | 2.81756141 |
| 42 | Gait imbalance (HP:0002141) | 2.79776140 |
| 43 | Syncope (HP:0001279) | 2.78596784 |
| 44 | Congenital primary aphakia (HP:0007707) | 2.75527706 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.74324346 |
| 46 | Palpitations (HP:0001962) | 2.72283964 |
| 47 | Hypolipoproteinemia (HP:0010981) | 2.71047942 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.67879533 |
| 49 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.66243395 |
| 50 | Nephrogenic diabetes insipidus (HP:0009806) | 2.64604363 |
| 51 | Hyperventilation (HP:0002883) | 2.59521731 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.59282365 |
| 53 | Gout (HP:0001997) | 2.58899218 |
| 54 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.56069677 |
| 55 | Calf muscle hypertrophy (HP:0008981) | 2.55112392 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.52134789 |
| 57 | Increased muscle lipid content (HP:0009058) | 2.50352433 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.49847928 |
| 59 | Lactic acidosis (HP:0003128) | 2.49724695 |
| 60 | Steatorrhea (HP:0002570) | 2.49374343 |
| 61 | Mitochondrial inheritance (HP:0001427) | 2.47622806 |
| 62 | Right ventricular cardiomyopathy (HP:0011663) | 2.39120134 |
| 63 | Bundle branch block (HP:0011710) | 2.38335784 |
| 64 | Progressive inability to walk (HP:0002505) | 2.38219917 |
| 65 | * Vomiting (HP:0002013) | 2.37118747 |
| 66 | Increased CSF lactate (HP:0002490) | 2.36398582 |
| 67 | Pancreatic cysts (HP:0001737) | 2.36362113 |
| 68 | Atrial fibrillation (HP:0005110) | 2.35937412 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.35611581 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.35549628 |
| 71 | Amyotrophic lateral sclerosis (HP:0007354) | 2.34592954 |
| 72 | Nephronophthisis (HP:0000090) | 2.34064603 |
| 73 | Complement deficiency (HP:0004431) | 2.31774858 |
| 74 | Azoospermia (HP:0000027) | 2.29841611 |
| 75 | Increased serum pyruvate (HP:0003542) | 2.29312544 |
| 76 | Abnormality of glycolysis (HP:0004366) | 2.29312544 |
| 77 | Delayed CNS myelination (HP:0002188) | 2.28656592 |
| 78 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27965722 |
| 79 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.27512279 |
| 80 | Hypothermia (HP:0002045) | 2.26979141 |
| 81 | Abnormality of B cell number (HP:0010975) | 2.24414137 |
| 82 | Epidermoid cyst (HP:0200040) | 2.24022690 |
| 83 | Attenuation of retinal blood vessels (HP:0007843) | 2.22897095 |
| 84 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.21988441 |
| 85 | Primary atrial arrhythmia (HP:0001692) | 2.21582342 |
| 86 | Increased intramyocellular lipid droplets (HP:0012240) | 2.20409181 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.19992137 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 2.19992137 |
| 89 | Prolonged QT interval (HP:0001657) | 2.19941177 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.18240224 |
| 91 | Hyperalaninemia (HP:0003348) | 2.18240224 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.18240224 |
| 93 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.17948071 |
| 94 | Abnormal social behavior (HP:0012433) | 2.17296944 |
| 95 | Impaired social interactions (HP:0000735) | 2.17296944 |
| 96 | Athetosis (HP:0002305) | 2.14574942 |
| 97 | * Methylmalonic aciduria (HP:0012120) | 2.14436976 |
| 98 | Heart block (HP:0012722) | 2.14282720 |
| 99 | Focal motor seizures (HP:0011153) | 2.14143903 |
| 100 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.12604233 |
| 101 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.12604233 |
| 102 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.12604233 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.12530993 |
| 104 | Hypoglycemic seizures (HP:0002173) | 2.12419392 |
| 105 | Abnormal protein glycosylation (HP:0012346) | 2.12379770 |
| 106 | Abnormal glycosylation (HP:0012345) | 2.12379770 |
| 107 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.12379770 |
| 108 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.12379770 |
| 109 | Broad-based gait (HP:0002136) | 2.11591482 |
| 110 | Abnormality of the renal medulla (HP:0100957) | 2.11340412 |
| 111 | Ventricular tachycardia (HP:0004756) | 2.10427136 |
| 112 | B lymphocytopenia (HP:0010976) | 2.10289568 |
| 113 | Ventricular arrhythmia (HP:0004308) | 2.09286497 |
| 114 | Fat malabsorption (HP:0002630) | 2.09248310 |
| 115 | Cholelithiasis (HP:0001081) | 2.08560128 |
| 116 | Atrioventricular block (HP:0001678) | 2.07904443 |
| 117 | Supraventricular tachycardia (HP:0004755) | 2.07761942 |
| 118 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.07021095 |
| 119 | Mucopolysacchariduria (HP:0008155) | 2.07021095 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 2.06570464 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.06224723 |
| 122 | Poor eye contact (HP:0000817) | 2.05759849 |
| 123 | Progressive cerebellar ataxia (HP:0002073) | 2.05733055 |
| 124 | Nausea (HP:0002018) | 2.05101245 |
| 125 | Abnormality of purine metabolism (HP:0004352) | 2.03980716 |
| 126 | Pancreatic fibrosis (HP:0100732) | 2.03962028 |
| 127 | Hyperglycemia (HP:0003074) | 2.03159449 |
| 128 | Rhabdomyolysis (HP:0003201) | 2.02701057 |
| 129 | Hyperbilirubinemia (HP:0002904) | 2.02612627 |
| 130 | Febrile seizures (HP:0002373) | 2.02257112 |
| 131 | Genital tract atresia (HP:0001827) | 2.02074470 |
| 132 | Inability to walk (HP:0002540) | 2.01520328 |
| 133 | Type II lissencephaly (HP:0007260) | 2.01179757 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 2.00930869 |
| 135 | Supraventricular arrhythmia (HP:0005115) | 2.00236173 |
| 136 | Chronic hepatic failure (HP:0100626) | 1.99117176 |
| 137 | Stomatitis (HP:0010280) | 1.99045195 |
| 138 | * Abnormality of vitamin B metabolism (HP:0004340) | 1.98667646 |
| 139 | Myokymia (HP:0002411) | 1.98453938 |
| 140 | CNS demyelination (HP:0007305) | 1.98452644 |
| 141 | Abnormal EKG (HP:0003115) | 1.97821139 |
| 142 | Abnormality of urine glucose concentration (HP:0011016) | 1.97777212 |
| 143 | Glycosuria (HP:0003076) | 1.97777212 |
| 144 | Cholecystitis (HP:0001082) | 1.97268904 |
| 145 | Abnormal gallbladder physiology (HP:0012438) | 1.97268904 |
| 146 | Tachypnea (HP:0002789) | 1.96617561 |
| 147 | Spontaneous abortion (HP:0005268) | 1.96606859 |
| 148 | Lipid accumulation in hepatocytes (HP:0006561) | 1.94906775 |
| 149 | Thyroiditis (HP:0100646) | 1.94463582 |
| 150 | Tubulointerstitial nephritis (HP:0001970) | 1.91208493 |
| 151 | Poor coordination (HP:0002370) | 1.90401675 |
| 152 | Intellectual disability, progressive (HP:0006887) | 1.89760591 |
| 153 | Large for gestational age (HP:0001520) | 1.88888657 |
| 154 | Absent speech (HP:0001344) | 1.88833567 |
| 155 | Renal Fanconi syndrome (HP:0001994) | 1.88617637 |
| 156 | Abnormal spermatogenesis (HP:0008669) | 1.84080378 |
| 157 | Short tibia (HP:0005736) | 1.84067571 |
| 158 | Abnormality of lateral ventricle (HP:0030047) | 1.83776212 |
| 159 | Adactyly (HP:0009776) | 1.83192614 |
| 160 | Vaginal atresia (HP:0000148) | 1.81833170 |
| 161 | Drooling (HP:0002307) | 1.78290070 |
| 162 | Tubulointerstitial abnormality (HP:0001969) | 1.77519927 |
| 163 | Hemiparesis (HP:0001269) | 1.77032764 |
| 164 | True hermaphroditism (HP:0010459) | 1.76606812 |
| 165 | Protruding tongue (HP:0010808) | 1.75324591 |
| 166 | Pachygyria (HP:0001302) | 1.75079452 |
| 167 | Disproportionate short-trunk short stature (HP:0003521) | 1.74872312 |
| 168 | Agitation (HP:0000713) | 1.73527483 |
| 169 | Tented upper lip vermilion (HP:0010804) | 1.71715041 |
| 170 | * Abnormality of vitamin metabolism (HP:0100508) | 1.71221393 |
| 171 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.70846935 |
| 172 | Type I transferrin isoform profile (HP:0003642) | 1.70430625 |
| 173 | Dialeptic seizures (HP:0011146) | 1.69970780 |
| 174 | Abolished electroretinogram (ERG) (HP:0000550) | 1.69260823 |
| 175 | Decreased circulating renin level (HP:0003351) | 1.68916083 |
| 176 | Hypoplasia of the fovea (HP:0007750) | 1.66645511 |
| 177 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.66645511 |
| 178 | Albinism (HP:0001022) | 1.66546441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.23566615 |
| 2 | TXK | 2.88014687 |
| 3 | EPHA4 | 2.71610810 |
| 4 | MAP4K2 | 2.68957813 |
| 5 | PHKG1 | 2.61104877 |
| 6 | PHKG2 | 2.61104877 |
| 7 | MAP2K7 | 2.60219309 |
| 8 | INSRR | 2.58982966 |
| 9 | MAP3K4 | 2.49666731 |
| 10 | MAP2K4 | 2.49544907 |
| 11 | PINK1 | 2.35749367 |
| 12 | MAP4K1 | 2.17417539 |
| 13 | ADRBK2 | 2.11626765 |
| 14 | ZAK | 2.03583812 |
| 15 | NTRK3 | 2.02972926 |
| 16 | TAOK3 | 2.02667926 |
| 17 | IRAK1 | 1.97053315 |
| 18 | LMTK2 | 1.95747859 |
| 19 | ACVR1B | 1.94212519 |
| 20 | TLK1 | 1.89497095 |
| 21 | PIK3CG | 1.86032000 |
| 22 | PDK4 | 1.83668519 |
| 23 | PDK3 | 1.83668519 |
| 24 | DAPK2 | 1.77367875 |
| 25 | MARK1 | 1.76656764 |
| 26 | CASK | 1.74776153 |
| 27 | BMPR1B | 1.72083980 |
| 28 | PIK3CA | 1.66034059 |
| 29 | OXSR1 | 1.62890068 |
| 30 | OBSCN | 1.60414288 |
| 31 | CAMK1D | 1.58817617 |
| 32 | ARAF | 1.58300003 |
| 33 | EPHA3 | 1.57515579 |
| 34 | CAMKK2 | 1.46663973 |
| 35 | MYLK | 1.44249705 |
| 36 | CDK19 | 1.42508717 |
| 37 | TIE1 | 1.35111336 |
| 38 | NEK9 | 1.35026100 |
| 39 | WNK4 | 1.33898481 |
| 40 | ERBB3 | 1.32156116 |
| 41 | STK39 | 1.30982282 |
| 42 | EIF2AK3 | 1.27723608 |
| 43 | GRK1 | 1.25776196 |
| 44 | NME1 | 1.25148362 |
| 45 | CSNK1G1 | 1.24274802 |
| 46 | CSNK1G2 | 1.19487575 |
| 47 | MST4 | 1.19235714 |
| 48 | SGK223 | 1.18191350 |
| 49 | SGK494 | 1.18191350 |
| 50 | IRAK2 | 1.16859517 |
| 51 | TNIK | 1.16093913 |
| 52 | PRKAA2 | 1.14975580 |
| 53 | BCR | 1.14502037 |
| 54 | TTN | 1.14303317 |
| 55 | PAK3 | 1.13421974 |
| 56 | CAMK1G | 1.12173319 |
| 57 | PKN1 | 1.11108604 |
| 58 | CSNK1A1L | 1.10128871 |
| 59 | CSNK1G3 | 1.10048762 |
| 60 | STK38L | 1.08273120 |
| 61 | CAMK2D | 1.07612005 |
| 62 | CAMK2A | 1.04742149 |
| 63 | DYRK2 | 1.04555892 |
| 64 | MAP3K12 | 1.04218884 |
| 65 | SGK2 | 1.03127206 |
| 66 | CAMK1 | 1.01507412 |
| 67 | PRKD3 | 1.00546826 |
| 68 | STK38 | 1.00398073 |
| 69 | CAMK2B | 0.98052487 |
| 70 | PDK2 | 0.96844459 |
| 71 | MAPK13 | 0.96787000 |
| 72 | MUSK | 0.96682503 |
| 73 | MAP3K7 | 0.96249243 |
| 74 | VRK1 | 0.95583097 |
| 75 | WNK3 | 0.95191816 |
| 76 | MAPK12 | 0.94081413 |
| 77 | MINK1 | 0.93216455 |
| 78 | PIM2 | 0.88757421 |
| 79 | RPS6KA5 | 0.87801522 |
| 80 | GRK7 | 0.87605396 |
| 81 | PRKCG | 0.87591922 |
| 82 | GRK5 | 0.86995961 |
| 83 | MOS | 0.86527086 |
| 84 | NTRK2 | 0.85656846 |
| 85 | CDK5 | 0.84838026 |
| 86 | MST1R | 0.84669921 |
| 87 | PRKCH | 0.83599006 |
| 88 | CAMK4 | 0.83188528 |
| 89 | CAMK2G | 0.82830002 |
| 90 | MAPK11 | 0.82424079 |
| 91 | MAP3K9 | 0.81633036 |
| 92 | MAP2K6 | 0.80541800 |
| 93 | MAPK15 | 0.80452597 |
| 94 | FER | 0.78508112 |
| 95 | PRKCE | 0.76440697 |
| 96 | TRIM28 | 0.74726353 |
| 97 | BMPR2 | 0.73866859 |
| 98 | PDPK1 | 0.73155406 |
| 99 | FGFR4 | 0.72762606 |
| 100 | PRKD1 | 0.71662113 |
| 101 | TAOK1 | 0.70387704 |
| 102 | STK24 | 0.69964913 |
| 103 | CAMKK1 | 0.68790770 |
| 104 | PRKAA1 | 0.67792699 |
| 105 | FRK | 0.66560718 |
| 106 | MKNK2 | 0.66322667 |
| 107 | PDK1 | 0.64152299 |
| 108 | NUAK1 | 0.62936336 |
| 109 | PRKACA | 0.62711134 |
| 110 | PIM1 | 0.62348024 |
| 111 | IKBKB | 0.61539665 |
| 112 | PRKD2 | 0.61293947 |
| 113 | SGK3 | 0.61060269 |
| 114 | AKT3 | 0.60492789 |
| 115 | DAPK3 | 0.57837941 |
| 116 | PRKCQ | 0.56023326 |
| 117 | CDK3 | 0.55387199 |
| 118 | CHUK | 0.55290863 |
| 119 | PRKACG | 0.55133710 |
| 120 | CDC42BPA | 0.54885963 |
| 121 | NTRK1 | 0.54412239 |
| 122 | PRKCI | 0.53189169 |
| 123 | PTK2B | 0.52113128 |
| 124 | MAP3K13 | 0.52108767 |
| 125 | RIPK4 | 0.51638462 |
| 126 | YES1 | 0.51531375 |
| 127 | PRKACB | 0.51100679 |
| 128 | NEK1 | 0.49443919 |
| 129 | MARK2 | 0.48777292 |
| 130 | SGK1 | 0.48625390 |
| 131 | TNK2 | 0.47571856 |
| 132 | RET | 0.47343957 |
| 133 | PRKCZ | 0.46794372 |
| 134 | MARK3 | 0.46700756 |
| 135 | CSNK1D | 0.46231040 |
| 136 | ERBB4 | 0.46155674 |
| 137 | ABL1 | 0.46055929 |
| 138 | PRKG1 | 0.45437264 |
| 139 | MAP3K14 | 0.45098163 |
| 140 | IKBKE | 0.44844199 |
| 141 | FLT3 | 0.44043606 |
| 142 | MAP2K1 | 0.43663517 |
| 143 | STK11 | 0.43651202 |
| 144 | NLK | 0.42850017 |
| 145 | ZAP70 | 0.42234334 |
| 146 | STK16 | 0.41897860 |
| 147 | DAPK1 | 0.40867078 |
| 148 | SYK | 0.40457315 |
| 149 | RAF1 | 0.37273024 |
| 150 | MAP3K5 | 0.36690789 |
| 151 | ADRBK1 | 0.36126671 |
| 152 | LYN | 0.34294260 |
| 153 | CSNK1A1 | 0.33692831 |
| 154 | PLK2 | 0.30445283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.04036689 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.80829071 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.79262452 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.77405845 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76670113 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.65724613 |
| 7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.57832151 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.49212837 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.39838884 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.32846023 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27730625 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.26985202 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26950153 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.15259673 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14022408 |
| 16 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13207224 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.09458723 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95669643 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.79831606 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.76071009 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.74643877 |
| 22 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.73373700 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72030355 |
| 24 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70004724 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.66288067 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59691549 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56235849 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.54909893 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.51291357 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49493473 |
| 31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.47381668 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.47153420 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.45562888 |
| 34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.40521026 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38373468 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38199969 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34591267 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.31317925 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29250308 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26108757 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.24688973 |
| 42 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.24651441 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23533080 |
| 44 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23039484 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21964635 |
| 46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.19406517 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18892902 |
| 48 | Nicotine addiction_Homo sapiens_hsa05033 | 1.18387867 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.17656153 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17425144 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13660359 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.11974656 |
| 53 | Bile secretion_Homo sapiens_hsa04976 | 1.10279854 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07546340 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.04609606 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03898816 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03370027 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02713391 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02519042 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01188956 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95674879 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.93403575 |
| 63 | Phototransduction_Homo sapiens_hsa04744 | 0.91919991 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90882779 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88490482 |
| 66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86471780 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86244525 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.85767565 |
| 69 | Protein export_Homo sapiens_hsa03060 | 0.85579622 |
| 70 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.84249592 |
| 71 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82986494 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81709582 |
| 73 | Asthma_Homo sapiens_hsa05310 | 0.81130620 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80749031 |
| 75 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.80082732 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79520070 |
| 77 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.78606998 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78482031 |
| 79 | Mineral absorption_Homo sapiens_hsa04978 | 0.74293458 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73615086 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.71943072 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70793349 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68840529 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.68715162 |
| 85 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68421508 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67885945 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67850896 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.67656557 |
| 89 | Allograft rejection_Homo sapiens_hsa05330 | 0.66797467 |
| 90 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65503206 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64639898 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.63076596 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.61030281 |
| 94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60193113 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59966450 |
| 96 | RNA degradation_Homo sapiens_hsa03018 | 0.58296125 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57952565 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57648918 |
| 99 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.57188100 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.56656328 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56572333 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56128120 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55746844 |
| 104 | Insulin secretion_Homo sapiens_hsa04911 | 0.55344068 |
| 105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.53902147 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52923068 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52397409 |
| 108 | Lysine degradation_Homo sapiens_hsa00310 | 0.51102645 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50680121 |
| 110 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47771465 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.47713316 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47551325 |
| 113 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46524984 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45925410 |
| 115 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45572092 |
| 116 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43891211 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43608785 |
| 118 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43078449 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.42950875 |
| 120 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42179126 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42034767 |
| 122 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.42026321 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41654027 |
| 124 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39785469 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.39607760 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38148956 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.34512514 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34496526 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32531219 |
| 130 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.32171482 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31242772 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31000363 |
| 133 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30546672 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30299276 |
| 135 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.29989189 |
| 136 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29883708 |
| 137 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29540767 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29161748 |
| 139 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.28942659 |

